- Cambridge, Mass.-based Sarepta Therapeutics’ drug eteplirsen represents the first approved treatment for Duchenne’s muscular dystrophy.
- Lomaira is intended to help obese and overweight patients lose weight.
- India-based AuroBindo Pharma’s drug dolutegravir is intended to treat patients with HIV.
- Kyleena is a T-shaped intrauterine device that releases levonorgestrel, a hormone that stops the womb lining from thickening and consequently prevents pregnancy.
- Taiwan-based Medeon Biodesign developed a port site closure device called AbClose.
- Belgium-based Janssen Pharmaceuticals’ drug Invokamet XR may now be used as a first-line treatment to improve glycemic control in diabetic adults.
More articles on supply chain:
Supply chain tip of the week: Stick to facts not feelings
Wireless diagnostic device can detect flu strains within minutes
Self-directed robots are the new warehouse workers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
